Skip to main content
NCBI home page
Biochemical Journal logoLink to Biochemical Journal
. 1987 Jul 1;245(1):269–276. doi: 10.1042/bj2450269

Affinity-labelling of the anti-inflammatory drug and prostaglandin-binding site of 3 alpha-hydroxysteroid dehydrogenase of rat liver cytosol with 17 beta- and 21-bromoacetoxysteroids.

T M Penning 1, K E Carlson 1, R B Sharp 1
PMCID: PMC1148110  PMID: 3478045

Abstract

The homogeneous 3 alpha-hydroxysteroid dehydrogenase of rat liver cytosol binds prostaglandins with low micromolar affinity at its active site and is competitively inhibited by the non-steroidal and steroidal anti-inflammatory drugs [Penning, Mukharji, Barrows & Talalay (1984) Biochem. J. 222, 601-611]. To examine the portion of this binding site that accommodates the glucocorticoid side chain, we have synthesized 17 beta-bromoacetoxy-5 alpha-dihydrotestosterone (BrDHT) and 21-bromoacetoxydesoxycorticosterone (BrDOC) as affinity-labelling agents. Both these agents promote rapid inactivation of the purified enzyme in a time- and concentration-dependent manner. Analyses of the inactivation progress curves gave estimates of Ki for the inactivators and half-life (t1/2) for the enzyme at saturation (tau) as follows: Ki = 33 microM and tau = 18 s for BrDHT, and Ki = 10 microM and tau = 203 s for BrDOC. Under initial-velocity conditions BrDHT and BrDOC act as competitive inhibitors, yielding Ki values identical with those measured in the inactivation experiments. Both indomethacin and prostaglandin E2 can protect the enzyme from inactivation, yielding Ki values for these ligands consistent with those measured independently by competitive-inhibition studies. These data confirm that the bromoacetoxysteroids label the active site, which is coincident with the prostaglandin- and anti-inflammatory-drug-binding site. Neither gel filtration nor extensive dialysis restores activity to the enzyme inactivated with either affinity-labelling agent. Use of radioactive BrDHT or BrDOC, in which either the steroid portion is labelled with 3H or the bromoacetate portion is labelled with 14C, indicates that inactivation is accompanied by a stoichiometric incorporation of 0.7-1.0 molecules of inhibitor per enzyme monomer. The linkage that forms between the dehydrogenase with either [14C]BrDHT or [14C]BrDOC is stable to acid and base treatment. Complete acid hydrolysis of the enzyme inactivated with [14C]BrDHT, followed by amino acid analyses, indicates that 87% of the radioactivity is eluted with carboxymethylcysteine. An almost identical result is obtained with [14C]BrDOC, where at least 75% of the radioactivity is eluted with this amino acid. Thus BrDHT and BrDOC alkylate at least one reactive cysteine residue at the active site that may be of functional importance in binding the glucocorticoid side chain.

Full text

PDF
269

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Arias F., Sweet F., Warren J. C. Affinity labeling of steroid binding sites. Study of the active site of 20-beta-hydroxysteroid dehydrogenase with 6-beta- and 11 alpha-bromoacetoxyprogesterone. J Biol Chem. 1973 Aug 25;248(16):5641–5647. [PubMed] [Google Scholar]
  2. Hansen H. S. 15-hydroxyprostaglandin dehydrogenase. A review. Prostaglandins. 1976 Oct;12(4):647–679. doi: 10.1016/0090-6980(76)90044-7. [DOI] [PubMed] [Google Scholar]
  3. Hoff H. G., Schriefers H. Sexuell differenzierte und sexuell undifferenzierte 3alpha- und 3beta- Hydroxysteroid-Dehydrogenase-Aktivitäten und ihre intrazelluläre Lokalisation in der Rattenleber. Hoppe Seylers Z Physiol Chem. 1973 May;354(5):507–513. [PubMed] [Google Scholar]
  4. Nakano J., Anggård E., Samuelsson B. 15-Hydroxy-prostanoate dehydrogenase. Prostaglandins as substrates and inhibitors. Eur J Biochem. 1969 Dec;11(2):386–389. doi: 10.1111/j.1432-1033.1969.tb00784.x. [DOI] [PubMed] [Google Scholar]
  5. Penning T. M., Covey D. F., Talalay P. Inactivation of delta 5-3-oxo steroid isomerase with active-site-directed acetylenic steroids. Biochem J. 1981 Jan 1;193(1):217–227. doi: 10.1042/bj1930217. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Penning T. M. Inhibition of 5 beta-dihydrocortisone reduction in rat liver cytosol: a rapid spectrophotometric screen for nonsteroidal anti-inflammatory drug potency. J Pharm Sci. 1985 Jun;74(6):651–654. doi: 10.1002/jps.2600740614. [DOI] [PubMed] [Google Scholar]
  7. Penning T. M., Mukharji I., Barrows S., Talalay P. Purification and properties of a 3 alpha-hydroxysteroid dehydrogenase of rat liver cytosol and its inhibition by anti-inflammatory drugs. Biochem J. 1984 Sep 15;222(3):601–611. doi: 10.1042/bj2220601. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Penning T. M., Talalay P. Inhibition of a major NAD(P)-linked oxidoreductase from rat liver cytosol by steroidal and nonsteroidal anti-inflammatory agents and by prostaglandins. Proc Natl Acad Sci U S A. 1983 Jul;80(14):4504–4508. doi: 10.1073/pnas.80.14.4504. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Smithgall T. E., Harvey R. G., Penning T. M. Regio- and stereospecificity of homogeneous 3 alpha-hydroxysteroid-dihydrodiol dehydrogenase for trans-dihydrodiol metabolites of polycyclic aromatic hydrocarbons. J Biol Chem. 1986 May 15;261(14):6184–6191. [PubMed] [Google Scholar]
  10. Smithgall T. E., Penning T. M. Indomethacin-sensitive 3 alpha-hydroxysteroid dehydrogenase in rat tissues. Biochem Pharmacol. 1985 Mar 15;34(6):831–835. doi: 10.1016/0006-2952(85)90763-4. [DOI] [PubMed] [Google Scholar]
  11. Strickler R. C., Sweet F., Warren J. C. Affinity labeling of steroid binding sites. Study of the active site of 20beta-hydroxysteroid dehydrogenase with 2alpha-bromoacetoxyprogesterone and 11alpha-bromacetoxyprogesterone. J Biol Chem. 1975 Oct 10;250(19):7656–7662. [PubMed] [Google Scholar]
  12. Strickler R. C., Tobias B., Covey D. F. Human placental 17 beta-estradiol dehydrogenase and 20 alpha-hydroxysteroid dehydrogenase. Two activities at a single enzyme active site. J Biol Chem. 1981 Jan 10;256(1):316–321. [PubMed] [Google Scholar]
  13. Sweet F., Arias F., Warren J. C. Affinity labeling of steroid binding sites. Synthesis of 16 -bromoacetoxyprogesterone and its use for affinity labeling of 20 -hydroxysteroid dehydrogenase. J Biol Chem. 1972 Jun 10;247(11):3424–3433. [PubMed] [Google Scholar]
  14. TOMKINS G. M. A mammalian 3alpha-hydroxysteroid dehydrogenase. J Biol Chem. 1956 Jan;218(1):437–447. [PubMed] [Google Scholar]
  15. TOMKINS G. M. Enzymatic mechanisms of hormone metabolism. I. Oxidation-reduction of the steroid nucleus. Recent Prog Horm Res. 1956;12:125–133. [PubMed] [Google Scholar]
  16. Yuan B., Tai C. L., Tai H. H. 9-Hydroxyprostaglandin dehydrogenase from rat kidney. Purification to homogeneity and partial characterization. J Biol Chem. 1980 Aug 10;255(15):7439–7443. [PubMed] [Google Scholar]

Articles from Biochemical Journal are provided here courtesy of The Biochemical Society

RESOURCES